Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PAI-1 and tPA gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in a sample of Turkish population.

JPMA. The Journal of the Pakistan Medical Association - 1 Dec 2020

Sunnetcioglu Aysel, Berkoz Mehmet, Yildirim Metin, Bora Gulhan, Yalin Serap

Abstract excerpt

OBJECTIVES: The aim of this study was to assess the influence of plasminogen activator inhibitor-1 (PAI-1) 4G/5G or tissue plasminogen activator (tPA) I/D polymorphisms in chronic obstructive pulmonary disease (COPD) cases in a sample of Turkish population. METHODS: PAI-1 4G/5G and tPA Alu-repeat I/D genetic polymorphisms in 153 COPD subjects and 160 controls were investigated using PCR-RFLP and PCR methods,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Frequency
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Plasminogen Activator Inhibitor 1

Share to Polymorphism, Genetic

Share to Pulmonary Disease, Chronic Obstructive

Share to Tissue Plasminogen Activator

Source

Identifiers

PMID: 33475534
DOI: 10.5455/JPMA.250

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PAI-1 and tPA gene polymorphisms and susceptibility to chronic obstructive pulmonary disease in a sample of Turkish population.PMID 33475534Read ↗

Association Between Plasminogen Activator Inhibitor-1-675 4G/5G Insertion/Deletion Polymorphism and Chronic Obstructive Pulmonary Disease.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 and susceptibility to lung cancer: a population genetics perspective.Semantic proximity Read ↗

Plasminogen activator inhibitor type-1 gene 4G/5G polymorphism in Turkish adult patients with asthma.Semantic proximity Read ↗

Polymorphism 4G/5G of the plasminogen activator inhibitor 1 gene as a risk factor for the development of allergic rhinitis symptoms in patients with asthma.Semantic proximity Read ↗

[Genetics risk factors in chronic obstructive pulmonary disease].Semantic proximity Read ↗

The -675 4G/5G polymorphism in plasminogen activator inhibitor-1 gene is associated with risk of asthma: a meta-analysis.Semantic proximity Read ↗

Evaluation of whether the ACE gene I/D polymorphism constitutes a risk factor for chronic obstructive pulmonary disease in the Turkish population.Semantic proximity Read ↗

Role of proteinase-activated receptor-1 gene polymorphisms in susceptibility to chronic obstructive pulmonary disease.Semantic proximity Read ↗

MMP14 gene polymorphisms in chronic obstructive pulmonary disease.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 gene promoter 4G/5G polymorphism and risks of peripherally inserted central catheter-related venous thrombosis in patients with lung cancer: a prospective cohort study.Semantic proximity Read ↗

Plasminogen activator inhibitor-1 and angiotensin converting enzyme gene polymorphisms in Turkish asthmatic children.Semantic proximity Read ↗

Association between TNF-α -308 G/A polymorphism and COPD susceptibility: a meta-analysis update.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.